- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07278466
The COMParing App Support Strategies Study
Study Overview
Status
Conditions
Detailed Description
Participants will be randomly assigned to various support conditions that vary across three binary factors,
- Coaching session vs no coaching
- On-demand email support (Yes/No)
- Microsupport messages (Yes/No)
Participants will be screened for eligibility using a web-based screener that assesses inclusion and exclusion criteria. Eligible participants will receive a study overview and will have the option to go through an online consent process. After giving consent, participant will receive a text message to assess their ability to receive text messages and tab on a link embedded in the text message. Those who failed to go through this process will be screened out.
Participants consented will complete a baseline survey consisting of a series of questionnaires and daily check-in assessment sent to their phone. Only those who successfully complete the baseline survey and the first daily check-in survey will advance in the study. Participants will schedule a meeting with our study staff member after completing the baseline survey and first daily check-in survey. They will be assessed through questionnaires at baseline, weekly during the 4-week intervention period, and at 6-month follow-up. They will also complete daily check-in survey twice a day throughout the intervention.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Wendy Lau, PhD
- Phone Number: 608-890-2747
- Email: wendy.lau@wisc.edu
Study Locations
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53703
- Recruiting
- Center for Healthy Minds
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Elevated symptoms of depression and/or anxiety (PHQ-9 greater than or equal to 10, GAD-7 greater than or equal to 10)
- Proficiency in English
- Access to a smartphone and internet
- Ability to receive text messages
Exclusion Criteria:
- Non-US citizen or legal resident (green card holder)
- History of psychosis or mania
- Suicidal ideation or thoughts of self-harm indicated by PHQ9 item 9 and BDI item 9
- Individuals who do not provide the information required for GUID generation
- Previous participation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Microsupport
|
Text message microsupport throughout the 4 week intervention period
Other Names:
Participant is randomized to receive a 30-minute information session
|
|
Experimental: Coaching
|
Participant is randomized to receive a 30-minute meditation coaching session
|
|
Experimental: Coaching with On-Demand email support
|
Participant is randomized to receive a 30-minute meditation coaching session
email support throughout the 4 week intervention period
Other Names:
|
|
Experimental: Coaching and microsupport
|
Participant is randomized to receive a 30-minute meditation coaching session
Text message microsupport throughout the 4 week intervention period
Other Names:
|
|
Experimental: Coaching with On-Demand email support and microsupport
|
Participant is randomized to receive a 30-minute meditation coaching session
email support throughout the 4 week intervention period
Other Names:
Text message microsupport throughout the 4 week intervention period
Other Names:
|
|
No Intervention: No additional support
|
|
|
Experimental: On-Demand email support
|
email support throughout the 4 week intervention period
Other Names:
Participant is randomized to receive a 30-minute information session
|
|
Experimental: On-Demand email support and microsupport
|
email support throughout the 4 week intervention period
Other Names:
Text message microsupport throughout the 4 week intervention period
Other Names:
Participant is randomized to receive a 30-minute information session
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS) Score
Time Frame: baseline, week 1, week 2, week 3, week 4, 6-month follow up
|
The PHQ-ADS is scored by summing responses to its 16 items (combining the PHQ-9 and GAD-7), with scores ranging from 0 to 48, where higher scores indicate greater distress.
Each item uses a 0-3 scale (0=Not at all, 3=Nearly every day).
Common interpretation is 10 (mild), 20 (moderate), and 30 (severe) distress.
|
baseline, week 1, week 2, week 3, week 4, 6-month follow up
|
|
Anxiety Measured from Evening Daily Diary Items
Time Frame: Daily through the Intervention Period (up to 4 weeks)
|
Evening daily diary will include a single-item measure of anxiety using the HMP.
Each item will be rated on a 5-point Likert scale (1 = not at all, 5 = very much).
Higher scores indicate more severe anxiety.
Daily means with and standard deviations will be reported.
|
Daily through the Intervention Period (up to 4 weeks)
|
|
Depression Measured from Evening Daily Diary Items
Time Frame: Daily through the Intervention Period (up to 4 weeks)
|
Evening daily diary will include a single-item measures of depression using the HMP.
Each item will be rated on a 5-point Likert scale (1 = not at all, 5 = very much).
Higher scores indicate more severe depression.
Daily means with and standard deviations will be reported.
|
Daily through the Intervention Period (up to 4 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PROMIS Toolbox Meaning and Purpose Score
Time Frame: baseline, week 1, week 2, week 3, week 4, 6-month follow up
|
The PROMIS / NIH Toolbox Meaning and Purpose is a computer-adaptive measure where participants report how much meaning and purpose they experience in life (e.g., "I understand my life's meaning").
It is scored on a 5-point Likert scale where 1 = strongly disagree to 5 = strongly agree.
It provides total scores as T-scores (mean = 50, SD = 10) where higher scores indicate more meaning and purpose in life.
|
baseline, week 1, week 2, week 3, week 4, 6-month follow up
|
|
NIH Toolbox Loneliness Score
Time Frame: baseline, week 1, week 2, week 3, week 4, 6-month follow up
|
The NIH Toolbox Loneliness is a 5-item questionnaire where participants report how often in the past week they have felt loneliness.
It is scored on a 5-point Likert scale where 1 = never to 5 = always.
The total possible range of scores is 5-25 where higher scores indicate a greater sense of loneliness.
|
baseline, week 1, week 2, week 3, week 4, 6-month follow up
|
|
Experiences Questionnaire Decentering subscale Score
Time Frame: baseline, week 1, week 2, week 3, week 4, 6-month follow up
|
The Decentering subscale of the Experience Questionnaire is an 11-item questionnaire where participants report on their ability to decenter from their experience.
It is scored on a 5-point Likert scale where 1 = never to 5 = all the time.
The total possible range of scores is 11-55 where higher scores indicate a greater ability to decenter from experience.
|
baseline, week 1, week 2, week 3, week 4, 6-month follow up
|
|
Healthy Minds Index (HM Index) - Awareness Score
Time Frame: baseline, week 4, 6-month follow up
|
The HM Index is a 17-item questionnaire assessing qualities trained in the HMP app (awareness, connection, insight, purpose).
It is scored on a 0- to 4-point Likert scale where 0 = a low amount (e.g., never, not at all, none of the time) and 4 = a higher amount (e.g., always, to the highest degree, all of the time) of a particular quality.
Total scores for the Awareness subscale is 0 to 16 where higher scores indicate more awareness.
|
baseline, week 4, 6-month follow up
|
|
Healthy Minds Index (HM Index) - Connection Score
Time Frame: baseline, week 4, 6-month follow up
|
The HM Index is a 17-item questionnaire assessing qualities trained in the HMP app (awareness, connection, insight, purpose).
It is scored on a 0- to 4-point Likert scale where 0 = a low amount (e.g., never, not at all, none of the time) and 4 = a higher amount (e.g., always, to the highest degree, all of the time) of a particular quality.
Total scores for the Connection subscale range from 0 to 24, where higher scores indicate more connection.
|
baseline, week 4, 6-month follow up
|
|
Healthy Minds Index (HM Index) - Insight Score
Time Frame: baseline, week 4, 6-month follow up
|
The HM Index is a 17-item questionnaire assessing qualities trained in the HMP app (awareness, connection, insight, purpose).
It is scored on a 0- to 4-point Likert scale where 0 = a low amount (e.g., never, not at all, none of the time) and 4 = a higher amount (e.g., always, to the highest degree, all of the time) of a particular quality.
Total scores for the Insight subscale range from 0 to 12, where higher scores indicate more insight.
|
baseline, week 4, 6-month follow up
|
|
Healthy Minds Index (HM Index) - Purpose Score
Time Frame: baseline, week 4, 6-month follow up
|
The HM Index is a 17-item questionnaire assessing qualities trained in the HMP app (awareness, connection, insight, purpose).
It is scored on a 0- to 4-point Likert scale where 0 = a low amount (e.g., never, not at all, none of the time) and 4 = a higher amount (e.g., always, to the highest degree, all of the time) of a particular quality.
Total scores for the Purpose subscale range from 0 to 16, where higher scores indicate more purpose.
|
baseline, week 4, 6-month follow up
|
|
Growth Mindset Scale Adapted for Well-being Score
Time Frame: baseline, week 4, 6-month follow up
|
The Wellbeing Growth Mindset scale is a 3-item scale where participants report whether they believe wellbeing is malleable (e.g., "Your well-being is something about you that you can't change very much.").
It is scored on a 6-point Likert scale where 1 is "strongly disagree" to 6 being "strongly agree."
Total scores range from 3 to 18 where higher scores indicate greater wellbeing growth mindset.
|
baseline, week 4, 6-month follow up
|
|
Digital Working Alliance Inventory (DWAI) Score
Time Frame: week 1, week 2, week 3, week 4
|
DWAI is a six-item questionnaire designed to assess the working alliance within the Healthy Minds Program (HMP) app.
It measures the user's connection and agreement with the app, focusing on the bond, tasks, and goals of the therapeutic relationship.
It is scored on a 7-point Likert scale, with scores ranging from 6-42.
Higher scores indicate a stronger working alliance with the HMP app.
|
week 1, week 2, week 3, week 4
|
|
Morning Daily Diary Items
Time Frame: Daily through the Intervention Period (up to 4 weeks)
|
Morning daily diary will include single-item measures of mindfulness, decentering, connection, purpose, depression, anxiety, happiness, energy, stress, busyness, rumination (2 items), sleep quality, motivation to practice meditation, and expectations and challenges related to using the HMP.
Each item will be rated on a 5-point Likert scale (1 = not at all, 5 = very much).
Higher scores indicate greater levels of the respective construct, such as higher mindfulness, greater decentering, stronger sense of purpose, greater happiness, more severe depression or anxiety, better sleep quality, or greater motivation and perceived helpfulness or frustration with HMP use that morning.
Daily means with and standard deviations will be reported.
|
Daily through the Intervention Period (up to 4 weeks)
|
|
Evening Daily Diary Items
Time Frame: Daily through the Intervention Period (up to 4 weeks)
|
Evening daily diary will include single-item measures of mindfulness, decentering, connection, purpose, depression, anxiety, happiness, energy, happy event, stress exposure, rumination (2 items), and expectations related to using the HMP.
Each item will be rated on a 5-point Likert scale (1 = not at all, 5 = very much).
Higher scores indicate greater levels of the respective construct, such as higher mindfulness, greater decentering, stronger sense of purpose, more severe depression or anxiety, happy event and stressor exposure experience, or greater motivation and perceived helpfulness with HMP use that day.
Daily means with and standard deviations will be reported.
|
Daily through the Intervention Period (up to 4 weeks)
|
|
Percentage of participants with a formal practice
Time Frame: Daily through the Intervention Period (up to 4 weeks)
|
Participants' engagement in formal mindfulness practice will be assessed twice a day with a binary yes/no response.
Formal practice is defined as using the HMP app.
|
Daily through the Intervention Period (up to 4 weeks)
|
|
Percentage of participants with an informal practice
Time Frame: Daily through the Intervention Period (up to 4 weeks)
|
Participants' engagement in informal mindfulness practice will be assessed twice a day with a 5-point Likert scale (1 = not at all, 5 = all day long).
Informal practice is defined as applying well-being practices in daily life.
|
Daily through the Intervention Period (up to 4 weeks)
|
|
Percentage of participants who received a text message and applied a well-being strategy
Time Frame: Daily through the Intervention Period (up to 4 weeks)
|
Participants will indicate whether they received a text message from the study that day (yes/no).
If they respond "yes," they will then report whether the message encouraged them to apply a wellbeing strategy (yes/no) and rate the extent to which they applied the strategy in their day-to-day activities on a 5-point Likert scale (1 = not at all, 5 = very much).
|
Daily through the Intervention Period (up to 4 weeks)
|
|
Extent to which participants applied a well-being strategy in their day-to-day activities
Time Frame: Daily through the Intervention Period (up to 4 weeks)
|
Participants who received a text message and applied a well-being strategy will be asked to rate the extent to which they applied the strategy in their day-to-day activities on a 5-point Likert scale (1 = not at all, 5 = very much).
|
Daily through the Intervention Period (up to 4 weeks)
|
|
Patient-Reported Outcomes Measurement Information System (PROMIS) Depression
Time Frame: baseline, week 1, week 2, week 3, week 4, 6-month follow up
|
A computer-adaptive measure of feelings of depression scored from 1 to 5 where higher numbers indicate increased feelings of depression.
It provides t-scores with a mean of 50 and SD of 10
|
baseline, week 1, week 2, week 3, week 4, 6-month follow up
|
|
Beck's Depression Inventory (BDI) Item 9 Score
Time Frame: baseline, week 1, week 2, week 3, week 4, 6-month follow up
|
Item 9 on the Beck Depression Inventory (BDI) assesses suicidal thoughts or wishes.
The possible scores for this item are 0, 1, 2, or 3, corresponding to different levels of severity.
A score of 0 indicates no suicidal thoughts, while higher scores indicate increasing severity of suicidal ideation.
|
baseline, week 1, week 2, week 3, week 4, 6-month follow up
|
|
Five Facet Mindfulness Questionnaire (Awareness subscale) Score
Time Frame: baseline, week 1, week 2, week 3, week 4, 6-month follow up
|
The Five Facet Mindfulness Questionnaire Acting with Awareness Subscale is an 8-item subscale where participants report on their general ability to focus.
It is scored on a 5-point Likert scale where 1 = never or very rarely true to 5 = very often or always true.
The total possible range of scores is 8-40 where higher scores indicate a greater ability to focus.
|
baseline, week 1, week 2, week 3, week 4, 6-month follow up
|
|
Change in PROMIS Anxiety Score
Time Frame: baseline, week 1, week 2, week 3, week 4, 6-month follow up
|
The PROMIS Anxiety Score is a computer adaptive measure of feelings of anxiety in the past 7 days.
This is a computer-adaptive survey scored on a 5-point Likert scale from 1 (never) to 5 (always) with higher scores indicating increased anxiety.
It provides t-scores with a mean of 50 and SD of 10.
Higher t-scores indicate higher levels of anxiety.
|
baseline, week 1, week 2, week 3, week 4, 6-month follow up
|
|
Medication and Therapy Questionnaire
Time Frame: baseline, week 4, 6-month follow up
|
The 3-item Medication and Therapy Questionnaire collects information on whether participants received medication or therapy for mental health concerns in the past month.
Each item is a yes/no question.
|
baseline, week 4, 6-month follow up
|
|
Change in WHODAS 2.0
Time Frame: baseline, week 4, 6-month follow up
|
WHODAS 2.0 is a 12-item measure which evaluates healthy-related disability in the past 30 days across 6 domains (cognition, mobility, self-care, getting along, life activities, and participation).
It is scored on a 5-point Likert scale were 0 = None and 4 = Extreme or cannot do.
The total score ranges from 0 to 48 with higher scores indicating higher level of impairment.
|
baseline, week 4, 6-month follow up
|
|
Change in the Positive & Negative Affect Schedule (PANAS-SF)
Time Frame: baseline, week 4, 6-month follow up
|
PANAS is a 10-item measure assessing positive (5 items) and negative (5 items) emotions using a 5-point Likert scale, in which 1 = Never and 5 = Always.
The total score of each scale ranges from 5-25.
Positive Affect score means higher levels of enthusiastic, alert, and pleasurable engagement.
A higher Negative Affect score indicates higher level of distress, nervousness, or anger.
|
baseline, week 4, 6-month follow up
|
|
Change in Alcohol Use Disorders Identification Test - Consumption (AUDIT-C)
Time Frame: baseline, week 4, 6-month follow up
|
AUDIT-C is a 3-item brief alcohol screen using a 5-point Likert scale.
The possible range of score is 0-12.
Higher scores suggest more hazardous alcohol use or active alcohol use disorders.
|
baseline, week 4, 6-month follow up
|
|
HMP Engagement Measure
Time Frame: week 4, 6-month follow up
|
HMP engagement is a 16-item measure which assess participant's usage experience with the Healthy Minds Program.
It is scored on a 5-point Likert scale where 1 = Strongly disagree to 5 = Strongly agree.
The total possible range of scores is 0-80 where higher scores indicate more positive engagement with the app.
|
week 4, 6-month follow up
|
|
Change in Adapted Client Service Receipt Inventory (CSRI)
Time Frame: baseline, 6-month follow up
|
The adapted CSRI includes five items assessing the number of primary care visits, mental health outpatient visits, emergency or urgent care visits, hospital nights, and mental health or sleep medications used during a 12-week recall period.
Responses are recorded as numeric counts ranging from zero to no fixed upper limit, with higher values indicating greater healthcare service use and higher associated healthcare costs.
|
baseline, 6-month follow up
|
|
Change in Work Productivity and Activity Impairment (WPA)
Time Frame: baseline, week 4, 6-month follow up
|
The WPAI is a 6-item questionnaire assessing health-related absenteeism, presenteeism, and activity impairment.
Scores are calculated as percentages with higher values indicating greater impairment and lower productivity.
|
baseline, week 4, 6-month follow up
|
|
Change in Flourishing Index score
Time Frame: baseline, week 1, week 2, week 3, week 4, 6-month follow up
|
The Flourishing Index is a 10-item questionnaire where participants report their general level of flourishing (e.g., well-being, health, etc.).
It is scored on a 0 to 10-point scale, with anchors varying across items.
The total score ranges from 0 to 100 with higher scores indicating higher flourishing.
|
baseline, week 1, week 2, week 3, week 4, 6-month follow up
|
|
PROMIS Sleep Disturbance
Time Frame: baseline, week 1, week 2, week 3, week 4, 6-month follow up
|
The PROMIS Sleep Disturbance Score is a measure of sleep in the past 7 days.
This is a computer-adaptive survey scored on a 5-point Likert scale with higher scores indicating increased sleep disturbance.
It provides t-scores with a mean of 50 and SD of 10.
Higher t scores indicate higher levels of sleep disturbances.
|
baseline, week 1, week 2, week 3, week 4, 6-month follow up
|
|
Supportive Accountability Inventory (SAI)
Time Frame: week 4, 6-month follow up
|
The SAI is an 8-item self-report tool to evaluate how users perceive the support and accountability provided by coaches in digital mental health interventions.
It uses a 7-point Likert scale (1 = Strongly Disagree; 7 = Strongly Agree).
Scores range from 8 to 56.
Higher scores indicate a stronger sense of supportive accountability from their coach perceived.
|
week 4, 6-month follow up
|
|
Ruminative Response Scale - Brooding subscale score
Time Frame: baseline, week 4, 6-month follow up
|
The RRS-Brooding subscale is a 5-item, 4-point measure of rumination.
Each item indicates the frequency of each event by rating a four-point Likert scale ranging from 1 (Almost never) to 4 (Almost always).
The total score ranges from 5-20, with higher scores indicating increased tendency to ruminate.
|
baseline, week 4, 6-month follow up
|
|
Treatment Expectancy Measure
Time Frame: week 4
|
This measure assesses how much the participant believes that the training program was helpful to them.
This has two aspects to it: (1) what the participant thought would happen and (2) what the participant feels will happen.
Each scale is scored from 1-9 with higher scores indicating better treatment expectancy.
|
week 4
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Simon Goldberg, PhD, UW Madison
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2025-1444
- EDUC/COUNSELING PSYCH (Other Identifier: UW Madison)
- 1R01MH139512-01 (U.S. NIH Grant/Contract)
- Protocol Version 4/2/2026 (Other Identifier: UW Madison)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression, Anxiety
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
International Association Psychosomatics And Health...RecruitingAnxiety | Anxiety DepressionUkraine
-
Duke Kunshan UniversityNational Natural Science Foundation of China; Kunshan Hospital of Traditional... and other collaboratorsNot yet recruitingAnxiety DepressionChina
-
University of PatrasUniversity of Bologna; Modena Health Authority; 6th Hellenic Health DistrictNot yet recruitingAnxiety DepressionGreece, Italy
-
University of California, BerkeleyUniversity of California, San Francisco; University of California, IrvineRecruiting
-
Moon (Guangzhou) Biotechnology Co., Ltd.Not yet recruiting
-
Florida State UniversityNational Cancer Institute (NCI)Recruiting
-
University of AlcalaCompletedAnxiety | Depressive Symptoms | Anxiety Symptoms | Subthreshold DepressionSpain
-
University Rovira i VirgiliUniversitat de Girona; University Ramon LlullActive, not recruiting
-
Örebro University, SwedenUppsala University; Göteborg University; Sahlgrenska University HospitalCompletedDepression/Anxiety | DGBISweden
Clinical Trials on Introductory Coaching Session
-
University of AdelaideOsteoporosis SACompleted
-
Dana-Farber Cancer InstitutePatty Brisben Foundation For Women's Sexual HealthCompletedOvarian CancerUnited States
-
Maisonneuve-Rosemont HospitalCompleted
-
Centre for Addiction and Mental HealthWithdrawnBipolar Disorder | Cognition | Cannabis Use DisorderCanada
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)Active, not recruitingSexual Function Disturbances | Cancer SurvivorshipUnited States
-
Centre for Addiction and Mental HealthCompletedMajor Depressive Disorder | Cognition | Cannabis Use DisorderCanada
-
Dana-Farber Cancer InstituteRecruitingCancer | Anxiety | SurvivorshipUnited States
-
NYU Langone HealthNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
George Washington UniversityUniversity of Pittsburgh; Medstar Health Research Institute; Quality Insights; Renal... and other collaboratorsCompletedChronic Kidney DiseasesUnited States
-
VA Office of Research and DevelopmentNot yet recruitingProstate CancerUnited States